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Background: Little is known on the etiology of early-onset ovarian cancer.  We conducted a 
population-based case-control study in California to evaluate the role of birth characteristics on 
the development of early-onset ovarian cancer.  
Methods: Data from the California Linkage Study of Early-onset Cancers, a population-based 
case-control linkage study, was used. This study included 895 first primary ovarian cancer patients 
who were born in 1978 – 2013 and diagnosed at the age of 0-37 years and 44,750 controls 
frequency matched on year of birth. We utilized multivariable logistic regression analyses with the 
backward selection procedure to estimate odds ratios (OR) and 95% confidence intervals (CIs). 
Results: In the multivariable model, compared with non-Hispanic whites, Hispanics (OR= 1.63, 
95% CI: 1.36 - 1.96), and other race/ethnicity (OR= 1.51, 95% CI: 1.23 - 1.84) had increased risk 
of early-onset ovarian cancer. In addition, every 500-gram increase in birth weight was associated 
with a 10% increase in the risk of early-onset ovarian cancer.  Among non-Hispanic whites, 
individuals with foreign-born mothers had a 55% (95% CI: 1.06 - 2.27) elevated risk of early-onset 
ovarian cancer than those with United States-born mothers. Having a non-private insurance type 
decreased risk of early-onset ovarian cancer among those 0-14 years of age (OR = 0.60, 95% CI: 
0.43 - 0.83); a similar decreased risk was also observed for teratoma (OR= 0.62, 95% CI: 0.42 - 
0.90).  
 
Conclusions: Our findings support the role of race/ethnicity and birth characteristics in the 
etiology of early-onset ovarian cancer. Risk factors of early-onset ovarian cancer show distinct 
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Ovarian cancer is the second most common gynecologic cancer, with 21,410 estimated new cases 
in 2021,  and the fifth leading cause of cancer death among females in the United States (US).1 
The overall incidence of ovarian cancer has been decreasing since mid-1980s to 2014, from 
16.6/100,000 to 11.8/100,000;2 however, according to the Surveillance, Epidemiology, and End 
Results (SEER) Program incidence data, an increased trend of pediatric ovarian cancer (< 15 years 
of age) has been observed since 2000.3 Ovarian tumors are derived from one of three cell types: 
epithelial cells, germ cells, and stromal cells.4 Common histologic subtypes of ovarian cancer 
differ by age and race/ethnicity.2,5-7 Germ cell tumors are the dominant histologic subtype in the 
prepubertal age group;8 starting from age 10 to 14 years, the incidence of epithelial cell tumors are 
reported to increase, and continue to increase to become the dominant subtype in adults.9 Hispanics 
have the highest incidence of germ cell tumors, yet non-Hispanic whites have higher incidence of 
epithelial ovarian cancer than other race/ethnicity groups.2 
Findings from previous studies suggest that prenatal and early life exposures are associated with 
the development of ovarian cancer in adulthood.10,11 The Million Women’s Study reported a non-
linear association between birthweight and risk of ovarian cancer among women ages 50 years and 
older.12 Similarly, a Danish study found that adult women (18 years or older) with lower (2.0-3.25 
kilograms) and higher (3.75-5.5 kilograms) birth weights had an increased risk of epithelial ovarian 
cancer, especially serous ovarian cancer, than those with a birthweight of 3.26-3.75 kilograms.10 
Moreover, it has been reported that women with rapid weight gain in infancy had higher risk of 
ovarian cancer death at ages of 32-68 years.11 Furthermore, prenatal events are also hypothesized 
to be linked with the development of germ cell tumors.13 
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There is a paucity of studies on the etiology of early-onset ovarian cancer. Of all malignant ovarian 
tumors,  epithelial ovarian cancers constitute more than 90%, germ cell tumors and sex cord-
stromal tumors consist of 2-3% and 5-6%, respectively.4 In addition, the majority of ovarian 
cancers develop after 45 years.14 Thus, studies on etiology of ovarian cancer tend to focus on 
epithelial ovarian tumors, and the median age of women included in the studies typically are 40 
years and older.15,16 However, distribution of histological subtype is different by age.17,18 Over 90% 
of ovarian cancers diagnosed among women 40 years of age and older are epithelial cell ovarian 
cancer.17 Germ cell tumors are reported to be diagnosed typically in women up to 30 years of age.18 
In addition, each histological subtype of ovarian cancer may have its own distinct causes.19 Thus, 
risk factors for early-onset ovarian cancer might be different from those of ovarian cancer that 
occur in late adulthood.   
To fill the knowledge gap, we conducted a population-based case-control study in California to 
evaluate the role of birth characteristics on the development of early-onset ovarian cancer.  
Methods 
We leveraged data from the California Linkage Study of Early-onset Cancers (CALSEC), a 
population-based case-control linkage study. The CALSEC linked California birth records 
maintained by the Center for Health Statistics and Informatics, California Department of Public 
Health from 1978-2013 with statewide cancer diagnosis data from the California Cancer Registry 
during 1988-2013.  
Study population 
This study included first primary ovarian cancer patients who were born in 1978–2013 and 
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diagnosed at the age of 0-37 years. Of the 912 first primary ovarian cancer patients, patients with 
missing information on residence (n = 2), maternal age (n = 1), birth weight (n = 1), birth order (n 
= 5), maternal birthplace (n = 2), history of stillbirth/miscarriage (n = 4), status of abnormality (n 
= 2) were excluded. 
For each case, 50 control subjects were randomly selected from the statewide birth records based 
on the same eligibility criteria. Controls were matched on year of birth and had no history of cancer 
diagnosis based on California Cancer Registry records at the time of linkage. 
The final cohort included 895 early-onset ovarian cancer cases and 44,750 controls. The study 
protocol was approved by the Institutional Review Boards at the California Health and Human 
Services Agency, University of California, Berkeley, and Yale University. 
We used the International Agency for Research on Cancer’s classification system to categorize 
ovarian cancer.20 This classification has been known to be the most appropriate classification 
system  in the pediatric and young adult population.21As shown in Table 1, we classified ovarian 
cancers as epithelial ovarian cancers , sex cord-stromal tumors, germ cell tumors, other specified 
malignant neoplasms (including Mullerian mixed tumor, carcinosarcoma) and unspecified 
malignant neoplasms. Germ cell tumors, the most common group of ovarian cancer in our study 
population, were further specified as teratoma, dysgerminoma, and yolk sac tumor, and other 
subtypes, including mixed germ cell tumor.22 
Variable of interest 
We abstracted birth characteristics and parental information from birth records. Birth 
characteristics included child’s year of birth (1978-1983, 1984-1990, 1991-2013), birthweight in 
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grams (<2500, 2500-2999, 3000-3499, 3500-3999, and ≥4000), race/ethnicity (Non-Hispanic 
white, Non-Hispanic black, Hispanic, Asian/Pacific Islander, Other), gestational age in weeks 
(22-36, 37-41, 42-44, Unknown), birth order (1st, 2nd, 3rd or higher), method of delivery (Vaginal 
or Cesarean section), and plurality (Singleton or Multiple). Parental information included 
maternal and paternal education level (High school or less, At least some college, Unknown), 
maternal age at delivery in years(<20, 20-24, 25-29, 30-34, ≥35), pregnancy complications 
(None, Yes, Unknown), history of previous cesarean section (No, Yes, Unknown), and history of 
miscarriage or stillbirth (Never, Ever), maternal birthplace (United States, Foreign), and mother’s 
private insurance status (Yes, No, Unknown), and paternal age at delivery in years (<20, 20-24, 
25-29, 30-34, 35-39, ≥40 years, or Unknown). Due to the small number of Asian/Pacific 
Islanders, we combined Asian/Pacific Islander and Other ethnicity as Other in the analyses. We 
also linked birth certificate with 1990 census (born before 1996), 2000 (born in 1996-2005) 
census data and 2008-2012 American Community Survey 5-year data (born in 2006 and later) to 
obtain percentage of population living below poverty and percentage of college and higher 
education in the census block group level. We further categorized percentage of population living 
below poverty in the census block group as <13%, 13-<26%, 26-<46%, ≥46%, and Unknown; 
and percentage of college and higher education in the census block group as 0-<35%, 35-<56%, 
≥56%, and Unknown. 
Statistical Methods 
Categorical variables were presented using frequencies and percentages, and continuous variables 
were summarized by means and standard deviations. Pearson’s χ2 test for categorical variables and 
the Student’s t-test for continuous variables were used to compare baseline characteristics across 
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cases and controls. To assess factors associated with risk of early-onset ovarian cancer, 
multivariable logistic regression models were used to estimate odds ratios (OR) and 95% 
confidence intervals (CI). The initial model included birthweight, gestational age, birth order, 
method of delivery, plurality, maternal age at delivery, pregnancy complications, history of 
previous cesarean section, history of miscarriage or stillbirth, race/ethnicity, maternal and paternal 
education level, paternal age at birth, maternal birthplace, percentage of population living below 
poverty in the census block group, percentage of college and higher education in the census block 
group, and mother’s private insurance status. After a backward selection using SAS and 
considering known general risk factors of reproductive cancers, the final model included race 
/ethnicity, birthweight in grams, maternal birthplace, percentage of college and higher education 
in the census block group, and mother’s private insurance status. The same variables were included 
in the multivariable logistic regression model for both the primary and stratified analyses by 
race/ethnicity, age at diagnosis (children: 0-14 years, adolescent: 15-19 years, and young adults: 
20-37 years), and ovarian cancer subtype. All analyses were conducted in SAS version 9.4 (SAS 
Institute, Inc., Cary, North Carolina) with 2 sided tests and a type I error of 5%.  
Results 
Of the 895 early-onset ovarian cancer patients, 548 (61.2%) were germ cell tumors and 273 (30.5%) 
were epithelial ovarian cancers (Figure 1). Among the subtypes of germ cell tumors, teratoma was 
the most frequent subtype (n = 242, 44.2%), followed by dysgerminoma (n = 128, 23.4%), and 
yolk sac tumor (n = 75, 8.4%). Nearly half (49.7%) of the women with early-onset ovarian cancer 
in our study were Hispanics.  
As shown in Figure 2, germ cell tumor was the most common subtype in all three race/ethnicity 
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groups, with 50.6%, 67.9% and 60.4% in non-Hispanic white, Hispanic and other race/ethnicity, 
respectively. When further stratified by age at diagnosis, among children and adolescents, germ 
cell tumors consisted of more than 67% of all ovarian cancers in both non-Hispanic white and 
Hispanic. Among young adults, 64.1% of non-Hispanic white women had epithelial ovarian cancer; 
nevertheless, among Hispanic women, 44.7% and 49.7% had germ cell and epithelial ovarian 
cancer, respectively.   
Compared with controls, cases were more likely to be Hispanics and Asian/Pacific Islanders, have 
higher birthweight and less-educated parents (Table 2). In addition, cases were more likely to have 
foreign-born mothers.  
Overall study population 
In multivariable analysis (Table 3), Hispanics (OR = 1.63, 95% CI: 1.36 - 1.96) and other 
race/ethnicity (OR = 1.51, 95% CI: 1.23 - 1.84) had an increased risk of ovarian cancer compared 
to non-Hispanic whites.  Birthweight was associated with ovarian cancer risk; the OR for a 500-
gram increase was 1.10 (95% CI: 1.04 - 1.17). In addition, compared with individuals whose 
mothers had private insurance, individuals whose mothers did not have a private insurance were 
associated with a decrease in the risk of early-onset ovarian cancer (OR = 0.79, 95% CI: 0.64 - 
0.98). 
Stratification by race/ethnicity  
Among both non-Hispanic whites and Hispanics, higher birthweight was associated with increased 
risk of ovarian cancer. Specifically, compared with those with a birthweight of 3000-3499 grams, 
non-Hispanic whites with a birthweight of 3500-3999 grams and Hispanics with a birthweight of 
13 
 
≥4000 grams had 61% (95% CI: 1.19 - 2.17) and 47% (95% CI: 1.06 - 2.04) increased risk of 
ovarian cancer, respectively (Table 4). In addition, risk of ovarian cancer increased by 55% (95% 
CI: 1.06 - 2.27) among non-Hispanic whites with foreign-born mothers than those with US-born 
mothers.  
Stratification by age at diagnosis  
Results in adolescent and young adults, were similar (Table 5). In both age groups, being Hispanic 
or other ethnicity, and having higher birthweight were associated with an increased risk of ovarian 
cancer. Notably, among adolescents, every 500-gram increase in birthweight was associated with 
a 15% increase in the risk of ovarian cancer. Among girls aged 0-14 years, not having a private 
insurance was associated with a decreased risk of ovarian cancer (OR = 0.60, 95% CI: 0.43 - 0.83). 
Stratification by ovarian cancer subtype 
Impact of race/ethnicity was observed on the risk of overall germ cell tumors, as well as the two 
major type of germ cell tumors. Compared with non-Hispanic whites, Hispanics had a nearly one-
fold increased risk of germ cell tumor (OR = 2.01, 95% CI: 1.58 - 2.55). Birthweight was 
associated with risk of epithelial ovarian cancer but not germ cell tumor (Table 6). Every 500-gram 
increase in birthweight was associated with a 14% (95% CI: 1.02 - 1.28) increase in the risk of 
epithelial ovarian cancer. In addition, women whose mothers did not have private insurance were 
at a decreased risk of germ cell tumor compared to those whose mother had private insurance (OR 




To the best of our knowledge, our study is the first to evaluate associations between birth 
characteristics and early-onset ovarian cancer. In this large population-based study, we found that 
Hispanics had an increased risk of developing early-onset ovarian cancer, especially germ cell 
tumors. Higher birthweight was also associated with the risk of early-onset ovarian cancer. In 
addition, our findings also suggested that a decreased risk of early-onset ovarian cancer among 
women whose mothers did not have private insurance compared to those whose mothers had 
private insurance. These associations were not observed in all subgroup analyses, but the estimated 
ORs were in the same direction.   
Race and ethnicity  
We found that Hispanics had an increased risk of developing early-onset ovarian cancer, especially 
germ cell tumors. This finding is consistent with incidence of non-epithelial cell tumors by 
race/ethnicity or geographic region. Studies using the SEER data also found that Hispanics had a 
higher  incidence of ovarian germ cell tumors than non-Hispanic whites.2,23 Another study also 
reported that among children 0-19 years, compared with non-Hispanic whites,  Hispanics had an  
increased risk for gonadal germ cell tumors.24 Given that the Hispanic population has increased by 
1.2 million between 2014 and 2015, which amount to approximately half of the increase in the 
overall US population,25  future research is needed to elucidate further public health implications 
of the increased risk of early-onset ovarian cancer in Hispanics. 
Our findings of increased risk of early-onset ovarian cancer among Hispanics and other race, as 
well as offspring of foreign-born non-Hispanic whites are in accord with reports of a possible role 
of genetic etiology in the pathogenesis of early-onset ovarian cancer.26 World widely, incidence of 
ovarian germ cell tumors was highest in Central America and Eastern Asia, and concomitantly  
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high among Hispanics and Asian Pacific Islanders in the US, suggesting a possible genetic 
etiology.26 Also, significant increase over time  in the incidence of ovarian germ cell tumors has 
been observed in Western Europe compared to other parts of Europe for ages 0-19 years.26 It has 
been suggested that different genetic patterns among separate geographic origins of Europeans 
may play a role in epithelial ovarian cancer.27 Associations between ovarian germ cell tumors and 
SNPs in specific genetic locations also support the possibility of genetic etiology.28 
Birthweight 
In our study, higher birthweight was associated with the risk of early-onset ovarian cancer in the 
overall population. Previous studies have inconsistent findings on the association between 
birthweight and risk of ovarian cancer.29,30 One study reported an overall 7% increase in risk of 
cancer for a birthweight increase of 1000 grams.30 Other studies reported non-linear associations 
between birthweight and risk of overall ovarian cancer.10,12 However, in a study using the data 
from the Nurses’ Health Study, there was no association between epithelial ovarian cancer and 
birthweight.29  
Birthweight has been speculated to be the outcome of fetal exposures that may impact the 
development of chronic diseases later in life.31 Notably, increased risk of ovarian cancer in later 
life in women with higher birthweight has been attributed to abnormally high gonadotropin release 
during fetal development and in infancy, promoting increased estrogen secretion resulting in infant 
weight gain and affecting the development of ovarian cancer later in life.10,11 Higher birthweight 
has also been associated with an increased number of cells at risk of developing cancer.32 In 
addition, changes in the programming of the insulin-like growth factor in the fetal period may 
accelerate cell proliferation after birth.33 Children with higher birthweight have increased levels of 
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insulin-like growth factor, which also facilitate cell proliferation responsible for tumorigenesis.34  
Socioeconomic status 
Our findings of decreased risk of early-onset ovarian cancer among women whose mothers did not 
have private insurance compared to those whose mothers had private insurance suggest that higher 
risk of early-onset ovarian cancer among women with high socioeconomic status (SES).   However, 
given that SES is a multifactorial measure, conflicting results regarding association of SES and 
incidence of ovarian cancer have been reported.35,36 A case-control study observed an increased 
risk of epithelial ovarian cancer among women younger than 45 years with at least 12 years of 
education or in high social status.37 Among Danish women ages 30 years and older, incidence of 
ovarian cancer was higher in women with higher income in comparison to women with middle 
income; in addition, a difference in incidence of ovarian cancer of 2/100,000 person-years between 
women with higher education and basic education was observed.38 However, a US study found 
higher education status was associated with decreased ovarian cancer risk among African-
American women.35 In addition, previous studies also found that  women who scored higher in the 
socioeconomically deprived index score36 or  had an education level of high school or less39 had a 
higher risk of being diagnosed with ovarian cancer at a more advanced stage, which suggests a 
potential role of lower SES on the delay of diagnosis of ovarian cancer.  Further studies on the role 
of SES and risk of ovarian cancer are needed. 
To date, our study is the most recently updated analysis of the epidemiology of early-onset ovarian 
cancer using a large geographic population. Strengths of our study were the large sample size, and 
the established temporal relationship between the potential risk factors studied and the diagnosis 
of ovarian cancer, owing to the design of this study. Limitations were that our sample represents a 
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specific geographic region, so our results may not be representative of the whole US population. 
Also, we could not account for potential California residents who moved out of state and 
afterwards got diagnosed with ovarian cancer. However, this possibility would have resulted in an 
increased number of cases in our study population and would not have affected the significance of 
our current conclusions. Since detailed clinical history such as height, body mass index, or 
presence of gestational diabetes and exposure information regarding ovarian cancer was largely 
unavailable due to the design of our study, our analysis was limited to information available from 
the birth certificates of study subjects. Missing data, small sample size in specific race/ethnicity 
and histologic subtype subgroups and unknown confounders limited our scope of analysis and 
limited the significance of our results.  
Conclusions 
Our findings support the role of race/ethnicity and birth characteristics in the etiology of early-
onset ovarian cancer. Risk factors of early-onset ovarian cancer show distinct features from those 
of later onset, possibly due to the distinct histologic subtypes across the age at diagnosis. 
Knowledge of risk factors of early-onset ovarian cancer may be helpful in preventing this disease 
by modifying possible external factors.  
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Table 1. Early-onset Ovarian Cancer Classification  
 International Classification of Diseases for 
Oncology – 3rd edition 
Epithelial ovarian cancer 8010-8231, 8246-8576, 9014-9015, 9110 
Sex cord-stromal tumor 8590-8671 
Germ cell tumor 8240-8245, 9060-9102 
   Dysgerminoma 9060 
   Yolk sac tumor 9071 
   Teratoma 9080-9084 
   Other  8240-8245, 9061-9070, 9072-9079, 9085-9102 
Other specified  8800-9000, 9105, 9120, 9260, 9364, 9473, 9580, 
9590-9975 




















Table 2. Characteristics of Study Population by Case/Control Status  
 Case  Control  
P value 
N %  N %  
Total 895  44,750   
Race/ethnicity       <0.01 
  Non-Hispanic white 263 29.4  18,118 40.5   
  Non-Hispanic black 75 8.4  3,882 8.7   
  Hispanic  445 49.7  18,079 40.4   
  Asian/Pacific Islander 103 11.5  3,985 8.9   
  Other 9 1.0  686 1.5    
Year of birth       1.00 
  1978-1983 305 34.1  15,250 34.1   
  1984-1990 295 33.0  14,750 33.0   
  1991-2013 295 33.0  14,750 33.0   
Birthweight, grams       <0.01 
  Median [IQR] 3370 [3010-3730]  3331[3005-3657]   
  <2500 43 4.8  2,879 6.4   
  2500-2999 168 18.8  7,793 17.4   
  3000-3499 309 34.5  17,880 40.0   
  3500-3999 289 32.3  12,405 27.7   
  ≥4000 86 9.6  3,793 8.5   
Gestational age, weeks      0.51  
  22-36 65 7.3  3,746 8.4   
  37-41  653 73.0  32,346 72.3   
  42-44  97 10.8  4,906 11.0   
25 
 
  Unknown 80 8.9  3,752 8.4   
Birth order       0.10 
  1st 341 38.1  18,347 41   
  2nd 279 31.2  13,971 31.2   
  3rd or higher 275 30.7  12,432 27.8   
Plurality       0.55 
  Singleton 875 97.8  43,747 97.8   
  Multiple 20 2.2  1,003 2.2   
Maternal age at delivery, years      0.91 
  Median [IQR] 26 [22-31]  26 [22-30]   
  <20 103 11.5  5,372 12.0   
  20-24 256 28.6  12,671 28.3   
  25-29 260 29.1  13,428 30.0   
  30-34 190 21.2  9,018 20.2   
  ≥35 86 9.6  4,261 9.5   
Maternal educational level      <0.01 
  High school or less 294 32.9  13,347 29.8   
  At least some college 125 14.0  7,573 16.9   
  Unknown 476 53.2  23,830 53.2   
Paternal age at delivery, years      0.91 
  <20 35 3.9  1,899 4.2   
  20-24 192 21.5  9,136 20.4   
  25-29 241 26.9  12,556 28.1   
  30-34 208 23.2  10,451 23.4   
  35-39 117 13.1  5,524 12.3   
  ≥40 63 7.0  3,065 6.9   
26 
 
  Unknown 39 4.4  2,119 4.7   
Paternal education level      0.02 
  High school or less 268 29.9  12,121 27.1   
  At least some college 131 14.6  7,494 16.8   
  Unknown 496 55.4  25,135 56.2   
Maternal birthplace       <0.01 
  United States 502 56.1  28,496 63.7   
  Foreign 393 43.9  16,254 36.3   
Method of delivery        0.40 
  Vaginal 718 80.2  35,712 79.8   
  Cesarean 177 19.8  9,038 20.2   
Pregnancy complications       0.60 
  None 729 81.5  36,519 81.6   
  Yes 114 12.7  5,605 12.5   
  Unknown 52 5.8  2,626 5.9   
History of previous cesarean section     0.43 
  No 792 88.5  39,450 88.2   
  Yes 60 6.7  3,097 6.9   
  Unknown 43 4.8  2,203 4.9   
History of miscarriage or stillbirth     0.40 
  Never 740 82.7  36,830 82.3   
  Ever 155 17.3  7,920 17.7   
% population living below poverty in the census block group  0.34 
  <13% 162 18.1  8,619 19.3    
  13-<26% 157 17.5  7,996 17.9   
  26-<46% 168 18.8  8,447 18.9   
27 
 
  ≥46% 176 19.7  7,749 17.3   
  Unknown 232 25.9  11,939 26.7   
% of college and higher education in the census block group   <0.01 
  <35% 259 28.9  10,889 24.3   
  35-<56% 203 22.7  10,682 23.9   
  ≥56% 203 22.7  11,262 25.2   
  Unknown 230 25.7  11,917 26.6   
Maternal private insurance status         
  Yes 188 21.0  9,113 20.4  0.56 
  No 184 20.6  9,483 21.2   
  Unknown 523 58.4  26,154 58.4   






































Table 3. Adjusted Odds Ratios and 95% Confidence Intervals for the Risk of Early-onset Ovarian 
Cancer (0-37 years), California Linkage Study of Early-Onset Cancers, 1988-2013. 
 Odds Ratio 95% Confidence interval 
Race/ethnicity   
     Non-Hispanic white 1.00  
     Hispanic 1.63 1.36 -1.96 
     Other 1.51 1.23 -1.84 
Birthweight, grams   
     <2500 0.87 0.63 -1.20 
     2500-2999 1.24 1.03 -1.50 
     3000-3499 1.00  
     3500-3999 1.38 1.17 -1.62 
     ≥4000 1.38 1.08 -1.75 
   Continuous (in 500 grams) 1.10 1.04 -1.17 
Maternal birthplace   
     United States 1.00  
     Foreign 1.13 0.97 - 1.31 
% of college and higher education in the census block group  
     <35% 1.00  
     35-<56% 0.88 0.73 - 1.06 
     ≥56% 0.87 0.72 - 1.06 
     Unknown 0.90 0.74 - 1.10 
Maternal private insurance status   
     Yes 1.00  
     No 0.79 0.64 - 0.98 
     Unknown 0.97 0.81 - 1.17 
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Table 4. Adjusted Odds Ratios and 95% Confidence Intervals for the Risk of Early-onset Ovarian 
Cancer (0-37 years) by Race/ethnicity 
 Non-Hispanic White  Hispanic 
Case Control OR (95% CI)  Case Control OR (95% CI) 
Total 263 5534   445 9,263  
Birthweight, grams    
 
   <2500 12 287 1.13 (0.61 - 2.11)  17 522 0.77 (0.46 - 1.27) 
   2500-2999 45 916 1.31 (0.90 - 1.91)  78 1,469 1.24 (0.94 - 1.64) 
   3000-3499 79 2,093 1.00  166 3,874 1.00 
   3500-3999 100 1,651 1.61 (1.19 - 2.17)  135 2,627 1.19 (0.94 - 1.50) 
   ≥4000 27 587 1.22 (0.78 - 1.91)  49 771 1.47 (1.06 - 2.04) 
   Continuous (in 500 grams) 1.06 (0.95-1.19)    1.08 (0.98 - 1.18) 
Maternal birthplace     
   United States 230 5,078 1.00  176 3,612 1.00 
   Foreign 33 456 1.55 (1.06 - 2.27)  269 5,651 1.02 (0.84 - 1.25) 
% of college and higher education in the census block group  
   <35% 38 526 1.00  187 3,849 1.00 
   35-<56% 57 1,186 0.65 (0.43 - 1.00)  96 2,270 0.86 (0.66 - 1.10) 
   ≥56% 83 1,616 0.68 (0.45 - 1.02)  73 1,671 0.88 (0.66 - 1.16) 
   Unknown 85 2,206 0.58 (0.39 - 0.88)  89 1,473 1.02 (0.77 - 1.35) 
Maternal private insurance 
status 
 
   
 
   Yes 65 1,040 1.00  84 1,791 1.00 
   No 28 469 0.91 (0.57 - 1.45)  129 3,525 0.77 (0.57 - 1.02) 
   Unknown 170 4,025 0.73 (0.53 - 1.01)  232 3,947 1.20 (0.92 - 1.58) 
Abbreviations: CI, confidence interval; OR, odds ratio. 




Table 5. Adjusted Odds Ratios and 95% Confidence Intervals for the Risk of Early-onset Ovarian Cancer (0-37 years) by Age at Diagnosis 
 0-14 years  15-19 years  20-37 years 
Case Control OR (95% CI)  Case Control OR (95% CI)  Case Control OR (95% CI) 
Total 259 12,950   238 11,900   398 19,900  
Race/ethnicity   
 
   
 
   
 
     Non-Hispanic white 73 4,565 1.00  59 4,584 1.00  131 8,969 1.00 
     Hispanic 134 5,916 1.39 (0.99-1.96)  132 5,006 2.06 (1.44-2.95)  179 7,157 1.56 (1.19-2.03) 
     Other 52 2,469 1.32 (0.90-1.93)  47 2,310 1.64 (1.10-2.46)  88 3,774 1.55 (1.16-2.06) 
Birthweight, grams 
 
   
 
   
 
     <2500 9 840 0.54 (0.27-1.08)  13 749 1.08 (0.60-1.97)  21 1,290 0.99 (0.62-1.58) 
     2500-2999 40 2,281 0.87 (0.60-1.26)  45 2,045 1.40 (0.96-2.03)  83 3,467 1.45 (1.10-1.92) 
     3000-3499 105 5,185 1.00  75 4,802 1.00  129 7,893 1.00 
     3500-3999 86 3,580 1.20 (0.90-1.60)  71 3,275 1.42 (1.02-1.97)  132 5,550 1.50 (1.18-1.92) 
     ≥4000 19 1,064 0.91 (0.55-1.49)  34 1,029 2.21 (1.46-3.34)  33 1,700 1.26 (0.86-1.86) 
   Continuous (in 500 grams)   1.10 (0.98-1.23)    1.15 (1.02-1.30)    1.07 (0.98-1.18) 
Maternal birthplace            
     United States 135 7,518 1.00  133 7,471 1.00  234 13,507 1.00 
     Foreign 124 5,432 1.17 (0.89-1.55)  105 4,429 0.99 (0.74-1.32)  164 6,393 1.20 (0.95-1.51) 
% of college and higher education in the census block group         
     <35% 84 3,670 1.00  83 3,398 1.00  92 3,821 1.00 
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     35-<56% 68 3,449 0.87 (0.62-1.21)  65 3,220 0.96 (0.68-1.34)  70 4,013 0.82 (0.60-1.13) 
     ≥56% 72 3,963 0.79 (0.55-1.11)  57 3,425 0.85 (0.60-1.23)  74 3,874 0.95 (0.69-1.30) 
     Unknown 35 1,868 0.83 (0.53-1.30)  33 1,857 0.85 (0.55-1.31)  162 8,192 0.94 (0.72-1.24) 
Maternal private insurance status 
 
   
 
   
 
     Yes 101 4,325 1.00  55 3,037 1.00  32 1,751 1.00 
     No 74 4,436 0.60 (0.43-0.83)  70 3,207 0.99 (0.68-1.43)  40 1,840 1.03 (0.64-1.66) 
     Unknown 84 4,189 0.87 (0.63-1.20)  113 5,656 1.11 (0.79-1.56)  326 16,309 1.08 (0.74-1.58) 
Abbreviations: CI, confidence interval; OR, odds ratio. 






Table 6. Adjusted Odds Ratios and 95% Confidence Intervals for the Risk of Early-onset Ovarian Cancer (0-37 years) by Histologic Subtype 
 
Epithelial ovarian cancer 
 Germ Cell Tumor 
 Overall  Teratoma  Dysgerminoma 
 Case Control OR (95% CI)  Case  Control OR (95% CI)  Case Control OR (95% CI)  Case Control OR (95% CI) 
Total 273 13,650   548 27,400   242 12,100   128 6,400  
Race/ethnicity              
     Non-Hispanic white 103 5,972 1.00  133 10,618 1.00  45 4,632 1.00  41 2,498 1.00 
     Hispanic 113 5,101 1.26 (0.92-1.73)  302 11,508 2.01 (1.58-2.55)  133 5,160 2.76 (1.89-4.05)  80 2,656 1.70 (1.08-2.69) 
     Other 57 2,577 1.33 (0.94-1.88)  113 5,274 1.68 (1.29-2.19)  64 2,308 2.92 (1.95-4.37)  7 1,246 0.33 (0.15-0.75) 
Birthweight, grams             
     <2500 12 889 0.87 (0.47-1.61)  29 1,747 0.89 (0.60-1.31)  13 769 0.80 (0.45-1.44)  10 413 1.69 (0.84-3.42) 
     2500-2999 53 2,349 1.46 (1.03-2.07)  94 4,774 1.03 (0.81-1.32)  43 2,101 0.99 (0.69-1.43)  18 1,104 1.08 (0.62-1.89) 
     3000-3499 84 5,463 1.00  206 10,931 1.00  95 4,798 1.00  41 2,508 1.00 
     3500-3999 93 3,775 1.64 (1.21-2.20)  172 7,654 1.22 (0.99-1.49)  67 3,392 1.04 (0.76-1.42)  45 1,837 1.47 (0.96-2.26) 
     ≥4000 31 1,174 1.78 (1.17-2.71)  47 2,294 1.14 (0.83-1.57)  24 1,040 1.27 (0.80-2.00)  14 538 1.59 (0.86-2.94) 
   Continuous (in 500 grams)  1.14 (1.02-1.28)    1.07 (0.99- 
1.16) 
   1.07 (0.95-1.20)    
1.08 (0.92-1.27) 
Maternal birthplace             
     United States 169 9,068 1.00  284 16,996 1.00  125 7,428 1.00  70 4,038 1.00 
34 
 
     Foreign 104 4,582 1.10 (0.82-1.46)  264 10,404 1.19 (0.98-1.43)  117 4,672 1.08 (0.82-1.42)  58 2,362 1.14 (0.75-1.72) 
% of college and higher education in the census block group           
     <35% 60 2,759 1.00  178 7,273 1.00  74 3,219 1.00  50 1,764 1.00 
     35-<56% 49 2,811 0.86 (0.58-1.27)  136 7,035 0.89 (0.70-1.11)  65 3,062 1.02 (0.73-1.44)  24 1,711 0.57 (0.34-0.94) 
     ≥56% 58 2,785 1.05 (0.72-1.54)  131 7,605 0.84 (0.66-1.07)  55 3,411 0.85 (0.58-1.23)  32 1,708 0.80 (0.49-1.29) 
     Unknown 106 5,295 0.99 (0.70-1.40)  103 5,487 0.88 (0.67-1.15)  48 2,408 1.04 (0.70-1.56)  22 1,217 0.71 (0.41-1.23) 
Maternal private insurance status    
 
   
 
    
     Yes 30 1,552 1.00  146 6,783 1.00  67 2,982 1.00  28 1,404 1.00 
     No 34 1,643 1.03 (0.62-1.70)  131 7,072 0.67 (0.52-0.86)  55 3,096 0.62 (0.42-0.90)  31 1,542 0.76 (0.44-1.30) 
     Unknown 209 10,455 1.04 (0.70-1.57)  271 13,545 0.93 (0.75-1.16)  120 6,022 0.86 (0.62-1.20)  69 3,454 0.99 (0.62-1.58) 
Abbreviations:  CI, confidence interval; OR, odds ratio. 






































Figure 2. Distribution of early-onset ovarian cancer (0-37 years) by race/ethnicity and histologic subtype, California Linkage Study of 






























Figure 3. Distribution of early-onset ovarian cancer (0-37 years) by race/ethnicity, histologic subtype, and age at diagnosis, California 
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